Definitive Healthcare Shares Rise 13% After Advent International Submits $1.02-Per-Share Proposal

Definitive Healthcare Corp. (NASDAQ:DH) shares rose 13% on Wednesday after Advent International submitted a non-binding proposal to acquire shares and units it does not already own for $1.02 per share in cash.

The proposed price represents a 36% premium to Definitive Healthcare’s 60-day volume-weighted average daily trading price of $0.75 per share as of the market close on August 31, 2026.

The proposal covers all outstanding shares of Class A common stock and Definitive OpCo Units that are not already owned by Advent and stockholder Jason Krantz.

Advent Proposal Includes Krantz Equity Rollover

In a letter dated September 1, 2026, Advent said its proposal assumes that Krantz, Definitive Healthcare’s founder and Executive Chairman, would roll over his Class A common stock and Definitive OpCo Units into equity of the surviving company.

Advent said the proposed transaction is not subject to a financing condition.

The proposal remains non-binding and does not represent a definitive agreement. The supplied information does not establish that a transaction will ultimately be negotiated, approved or completed.

Special Committee to Consider Potential Transaction

Advent said it would not proceed with the proposed acquisition without approval from Definitive Healthcare’s Special Committee.

The committee consists of disinterested and independent directors and has authority to evaluate, negotiate or reject the potential transaction.

The Special Committee is expected to receive advice from independent legal and financial advisers as it considers the proposal.

Advent described itself as a longtime Definitive Healthcare stockholder with knowledge of the company’s business and said it is prepared to negotiate and execute definitive transaction documentation expeditiously.

No timetable for reaching a definitive agreement was provided in the supplied information.

Definitive Healthcare Appoints Clay Ritchey as CEO

Separately, Definitive Healthcare announced that its board appointed Clay Ritchey as the company’s next Chief Executive Officer and as a member of the board, effective September 8, 2026.

Ritchey will succeed Kevin Coop, who departed as Chief Executive Officer and as a board member on August 31, 2026.

Coop had served as Definitive Healthcare’s CEO since June 2024.

The supplied information does not provide additional details about the circumstances surrounding Coop’s departure.

Shares Gain Following Buyout Proposal

Definitive Healthcare shares rose 13% during Wednesday’s session following disclosure of Advent’s proposal.

While the announcement and share-price increase occurred during the same session, the supplied information does not establish the extent to which the acquisition proposal was responsible for the stock’s movement.

The proposed $1.02-per-share transaction remains subject to consideration by the Special Committee and the negotiation and execution of definitive transaction documents.

Definitive Healthcare stock price